ELI LILLY & Co (LLY) operating KPIs

LLYNYSEPharmaceutical PreparationsFiscal year ends December 31

Financials through Q3 FY2026, quarter ended Sep 30, 2026Last filing: 10-Q on Oct 29, 2026Score 20/3026% above fair value

$1417.54+43.84 (+3.19%)

Close on Oct 30, 2026Market cap $1.33TP/E 46.0Yield 0.44%

Eli Lilly europe revenue ($M) ($M)

Form 10-Q / 10-K Geographic Information Note

Quarterly Annual

Latest, FY2025

11,558

Period ended Dec 31, 2025

Change on a year earlier

+67.0%

6,921 in FY2024

History

16 years

Since FY2010

Sources

Documents cited below

Annual history

Hover a value to see the sentence it was read from; calculated values show their formula

Period	Ended	Europe revenue ($M) ($M)	Year on year	Source
FY2025	Dec 31, 2025	11,558	+67.0%	Form 10-K (filed 2026-02-12) ↗
FY2024	Dec 31, 2024	6,921	+12.1%	Form 10-K (filed 2026-02-12) ↗
FY2023	Dec 31, 2023	6,175	+43.6%	Form 10-K (filed 2026-02-12) ↗
FY2022	Dec 31, 2022	4,299	-10.0%	Form 10-K (filed 2025-02-19) ↗
FY2021	Dec 31, 2021	4,777	+14.1%	Form 10-K (filed 2024-02-21) ↗
FY2020	Dec 31, 2020	4,188	+11.2%	Form 10-K (filed 2023-02-22) ↗
FY2019	Dec 31, 2019	3,765	+2.8%	Form 10-K (filed 2022-02-23) ↗
FY2018	Dec 31, 2018	3,663	+8.0%	Form 10-K (filed 2021-02-17) ↗
FY2017	Dec 31, 2017	3,391	-10.0%	Form 10-K (filed 2020-02-19) ↗
FY2016	Dec 31, 2016	3,768	-4.5%	Form 10-K (filed 2019-02-19) ↗
FY2015	Dec 31, 2015	3,944	-12.5%	Form 10-K (filed 2016-02-19) ↗
FY2014	Dec 31, 2014	4,507	+3.9%	Form 10-K (filed 2015-02-19) ↗
FY2013	Dec 31, 2013	4,338	+1.8%	Form 10-K (filed 2014-02-19) ↗
FY2012	Dec 31, 2012	4,260	-19.5%	Form 10-K (filed 2013-02-21) ↗
FY2011	Dec 31, 2011	5,291	+3.6%	Form 10-K (filed 2013-02-21) ↗
FY2010	Dec 31, 2010	5,106	–	Form 10-K (filed 2013-02-21) ↗

Cite this data

StockData. (2026). Eli Lilly Europe revenue ($M) ($M), annual FY2010–FY2025 [Data set]. Compiled from Eli Lilly SEC filings and investor materials. https://stockdatahq.com/stocks/lly/kpis/rev_geo_europe

See every metric in the Eli Lilly KPI table. Data updated Oct 25, 2026.